{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:19:58Z","timestamp":1763036398049},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anaesth"],"published-print":{"date-parts":[[1995,4]]},"DOI":"10.1007\/bf03010703","type":"journal-article","created":{"date-parts":[[2009,5,2]],"date-time":"2009-05-02T03:00:35Z","timestamp":1241233235000},"page":"281-286","source":"Crossref","is-referenced-by-count":36,"title":["Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy"],"prefix":"10.1007","volume":"42","author":[{"given":"Alison S.","family":"Carr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerrold","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Cunliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Elizabeth","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley A.","family":"Britt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03010703_CR1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-4613-2079-1_14","volume-title":"Malignant Hyperthermia","author":"BA Britt","year":"1987","unstructured":"Britt BA. Dantrolene \u2014 an update.In: Britt BA (Ed.). Malignant Hyperthermia. Boston: Martinus Nijhoff Publishing 1987: 325\u201367."},{"key":"BF03010703_CR2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1213\/00000539-199308000-00014","volume":"77","author":"Strazis K Prather","year":"1993","unstructured":"Prather Strazis K, Fox AW. Malignant hyperthermia: a review of published cases. Anesth Analg 1993; 77: 297\u2013304.","journal-title":"Anesth Analg"},{"key":"BF03010703_CR3","first-page":"547","volume-title":"Handbook of Experimental Pharmacology","author":"BA Britt","year":"1982","unstructured":"Britt BA. Malignant hyperthermia: a review.In: Milton AS (Ed.). Handbook of Experimental Pharmacology. Berlin: Springer-Verlag 1982: 547\u2013615."},{"key":"BF03010703_CR4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000542-198204000-00005","volume":"56","author":"MS Kolb","year":"1982","unstructured":"Kolb MS, Home ML, Martz R. Dantrolene in human malignant hyperthermia. A multicenter study. Anesthesiology 1982; 56: 254\u201362.","journal-title":"Anesthesiology"},{"key":"BF03010703_CR5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1399-6576.1991.tb03377.x","volume":"35","author":"H Ording","year":"1991","unstructured":"Ording H, Hedengran AM, Skovgaard LT. Evaluation of 119 anaesthetics received after investigation for susceptibility to malignant hyperthermia. Acta Anaesthesiol Scand 1991; 35: 711\u20136.","journal-title":"Acta Anaesthesiol Scand"},{"key":"BF03010703_CR6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/bja\/58.9.1001","volume":"58","author":"H Ording","year":"1986","unstructured":"Ording H, Nielsen VG. Atracurium and its antagonism by neostigmine (plus glycopyrrolate) in patients susceptible to malignant hyperthermia. Br J Anaesth 1986; 58: 1001\u20134.","journal-title":"Br J Anaesth"},{"key":"BF03010703_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00000542-198706000-00012","volume":"66","author":"MG Larach","year":"1987","unstructured":"Larach MG, Rosenberg H, Larach DR, Broennle AM. Prediction of malignant hyperthermia susceptibility by clinical signs. Anesthesiology 1987; 66: 547\u201350.","journal-title":"Anesthesiology"},{"key":"BF03010703_CR8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/bja\/60.4.445","volume":"60","author":"H Ording","year":"1988","unstructured":"Ording H, Fonsmark L. Use of vecuronium and doxapram in patients susceptible to malignant hyperthermia. Br J Anaesth 1988; 60: 445\u20139.","journal-title":"Br J Anaesth"},{"key":"BF03010703_CR9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1399-6576.1986.tb02479.x","volume":"30","author":"M Gielen","year":"1986","unstructured":"Gielen M, Viering W. 3-in-1 lumbar plexus block for muscle biopsy in malignant hyperthermia patients. Amide local anaesthetics may be used safely. Acta Anaesthesiol Scand 1986; 30: 581\u20133.","journal-title":"Acta Anaesthesiol Scand"},{"key":"BF03010703_CR10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00000542-198505000-00022","volume":"62","author":"A Berkowitz","year":"1985","unstructured":"Berkowitz A, Rosenberg H. Femoral block with mepivacaine for muscle biopsy in malignant hyperthermia patients. Anesthesiology 1985; 62: 651\u20132.","journal-title":"Anesthesiology"},{"key":"BF03010703_CR11","first-page":"179","volume-title":"Thermoregulation: Pathology, Pharmacology and Therapy","author":"BA Britt","year":"1991","unstructured":"Britt BA. Malignant hyperthermia \u2014 a review.In: Schonbaum E, Lomax P (Eds.). Thermoregulation: Pathology, Pharmacology and Therapy. New York: Pergamon Press, Inc. 1991: 179\u2013292."},{"key":"BF03010703_CR12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","volume":"80","author":"MG Larach","year":"1994","unstructured":"Larach MG, Localio AR, Allen GC, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994; 80: 771\u20139.","journal-title":"Anesthesiology"},{"key":"BF03010703_CR13","first-page":"378","volume-title":"Biostatistical Analysis","author":"JH Zar","year":"1984","unstructured":"Zar JH. Biostatistical Analysis, 2nd ed. Englewood Cliffs: Prentice-Hall, Inc., 1984: 378\u20139.","edition":"2nd ed"},{"key":"BF03010703_CR14","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1983.03330370053031","volume":"249","author":"JA Hanley","year":"1983","unstructured":"Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 1983; 249: 1743\u20135.","journal-title":"JAMA"},{"key":"BF03010703_CR15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03013807","volume":"30","author":"R Grinberg","year":"1983","unstructured":"Grinberg R, Edelist G, Gordon A. Postoperative malignant hyperthermia episodes in patients who received \u201csafe\u201d anaesthetics. Can Anaesth Soc J 1983; 30: 273\u20136.","journal-title":"Can Anaesth Soc J"},{"key":"BF03010703_CR16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","volume":"69","author":"MG Larach","year":"1989","unstructured":"Larach MG for the North American Malignant Hyperthermia Group. Standardization of the caffeine halothane muscle contracture test. Anesth Analg 1989; 69: 511\u20135.","journal-title":"Anesth Analg"},{"key":"BF03010703_CR17","first-page":"108","volume-title":"Malignant Hyperthermia: Current Concepts. International Course, Barcelona, Spain, September 15\u201317, 1988","author":"BA Britt","year":"1989","unstructured":"Britt BA. Elective and emergency treatment of malignant hyperthermic susceptible patients.In: Nalda F, Gottmann S, Khambatta HJ (Eds.). Malignant Hyperthermia: Current Concepts. International Course, Barcelona, Spain, September 15\u201317, 1988. Bad Homburg: Normed Verlag, 1989; 108\u201332."},{"key":"BF03010703_CR18","first-page":"499","volume":"60","author":"GA Gronert","year":"1981","unstructured":"Gronert GA, Milde JH. Variations in onset of porcine malignant hyperthermia. Anesth Analg 1981; 60: 499\u2013503.","journal-title":"Anesth Analg"}],"container-title":["Canadian Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03010703.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03010703\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03010703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:41:24Z","timestamp":1558478484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03010703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["BF03010703"],"URL":"https:\/\/doi.org\/10.1007\/bf03010703","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}